Medicure Ownership
MPH Stock | CAD 0.99 0.09 10.00% |
Shares in Circulation | First Issued 2002-06-30 | Previous Quarter 10.5 M | Current Value 10.4 M | Avarage Shares Outstanding 10.5 M | Quarterly Volatility 4.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Medicure |
Medicure Stock Ownership Analysis
About 27.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.52. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medicure recorded a loss per share of 0.2. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 2nd of November 2012. Medicure Inc., a pharmaceutical company, engages in the development and commercialization of therapies for the cardiovascular market in the United States. The company was founded in 1997 and is headquartered in Winnipeg, Canada. MEDICURE INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange. To find out more about Medicure contact Albert Friesen at 204 487 7412 or learn more at https://www.medicure.com.Medicure Outstanding Bonds
Medicure issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medicure uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medicure bonds can be classified according to their maturity, which is the date when Medicure has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Medicure Stock Analysis
When running Medicure's price analysis, check to measure Medicure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medicure is operating at the current time. Most of Medicure's value examination focuses on studying past and present price action to predict the probability of Medicure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medicure's price. Additionally, you may evaluate how the addition of Medicure to your portfolios can decrease your overall portfolio volatility.